
Immune Cell Biomarker Predicts Better Outcome in Head and Neck Cancer
Researchers find infiltrating lymphocytes tie to survival in patients with recurrent larynx cancer; findings suggest super-boosting the immune system before additional treatment.
January 24, 2019 11:45 AM